Campbell, United States
Saama, founded in 1997, is an innovative company operating at the intersection of AI, Analytics, and Life Sciences. Their mission is to expedite the delivery of therapeutic solutions to patients. Leveraging advanced AI and Machine Learning technologies, Saama enhances intelligence in clinical and commercial processes, significantly impacting the healthcare ecosystem.
A notable milestone for Saama includes powering the clinical trial that facilitated the development of the world’s first COVID-19 vaccine. With its headquarters in Campbell, CA, this globally distributed workforce is dedicated to transforming patient lives through groundbreaking technological advancements in the Pharmaceutical and Data Analytics industries.
In its last reported funding round on March 25, 2019, Saama secured a $40.00M Venture Round investment from Perceptive Advisors. This investment underscores confidence in Saama's capability to innovate and drive growth in life sciences, offering a promising outlook for prospective investors.
